Furthermore, to identify the molecular pathways associated with the BACE1 inhibition, the prostate cancer-specific pathway array analysis was performed in tumor tissues of both vehicle- and MK-8937 treated mice. This evidence concerns the gene BACE1 and prostate carcinoma.